Alaina Rachel Liu, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2615 E Clinton Ave, Fresno, CA 93703 Phone: 559-225-6100 |
Dr. Aryan Pazirandeh, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6767 N Fresno St, Fresno, CA 93710 Phone: 559-432-1000 Fax: 559-432-1034 |
Dr. Rick Wayne Ideta, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 7215 N 1st St, Ste 101, Fresno, CA 93720 Phone: 559-226-3937 Fax: 559-226-8305 |
Dr. Alesha Janelle Jensen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5151 N Palm Ave, Suite 150, Fresno, CA 93704 Phone: 559-229-7202 |
Angie Ng, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2615 E Clinton Ave, Fresno, CA 93703 Phone: 415-279-1979 |
Dr. Michael Ayala Mendoza, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7075 N Sharon Ave, Fresno, CA 93720 Phone: 559-486-2000 Fax: 559-389-5724 |
Dr. Alan Uyemura, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 6760 N West Ave Ste 103, Fresno, CA 93711 Phone: 559-226-6701 Fax: 559-226-6703 |
Amelene Gaoiran Bartlett, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2615 E Clinton Ave, Fresno, CA 93703 Phone: 559-225-6100 |
Dr. Ralph Handly, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7075 N Sharon Ave, Fresno, CA 93720 Phone: 559-486-2000 Fax: 559-256-8504 |
Aloha Family Optometric Group Optometrist Medicare: Medicare Enrolled Practice Location: 7215 N 1st St, Suite 101, Fresno, CA 93720 Phone: 559-226-3937 Fax: 559-226-8305 |
Dr. Pearl Tran Bao Thai, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1360 E Herndon Ave Ste 401, Fresno, CA 93720 Phone: 559-449-5010 |
Joelle Chan Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2615 E Clinton Ave, Fresno, CA 93703 Phone: 559-228-5366 |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5665 E Kings Canyon Rd, Fresno, CA 93727 Phone: 559-538-1574 |
Dr. Katherine Mulvey, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7780 N Fresno St, Suite 103, Fresno, CA 93720 Phone: 559-435-2060 Fax: 559-435-9060 |
Dr. Albert Yao, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 20 W Shaw Ave, #b, Fresno, CA 93704 Phone: 559-225-0848 |
Firstsight Vision Services, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5125 E Kings Canyon Rd, Fresno, CA 93727 Phone: 559-452-8477 Fax: 559-452-0684 |
Dr. Michael Kenichi Hayashi, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1111 E Herndon Ave, Suite 101, Fresno, CA 93720 Phone: 559-432-2200 Fax: 559-432-2203 |
David R. Sivas Optometrist Medicare: Medicare Enrolled Practice Location: 5781 E Kings Canyon Rd, Fresno, CA 93727 Phone: 559-251-8272 Fax: 559-251-4057 |
Dr. Christopher Gordon Fisher, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5430 N Palm Ave Ste 101, Fresno, CA 93704 Phone: 559-432-0606 Fax: 559-432-0608 |
Dr. John W Arteaga, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4041 N Fresno St, Ste 102, Fresno, CA 93726 Phone: 559-227-7512 Fax: 559-227-7574 |
News Archive
Scientists at the Monell Chemical Senses Center report that genes play a large role in determining individual differences in sour taste perception.
SuperSonic Imagine today announced that it has signed an exclusive distribution agreement with Canon Marketing Japan Inc. (Canon MJ) to develop the Japanese market.
In 2015, the estimated medical costs attributable to both fatal and nonfatal falls in older US adults was approximately $50 billion.
Eisai Inc. announced today that the Phase III ACCESS (A Controlled Comparison of Eritoran and Placebo in Patients with Severe Sepsis) trial of the investigational compound eritoran (E5564) will continue enrolling to the preset goal of 2,000 patients. As part of a planned interim analysis, an independent Data Monitoring Committee (DMC) has evaluated efficacy and safety data on the first 1,500 subjects to complete the 28-day follow-up in the Phase III ACCESS trial.
› Verified 3 days ago